HPQ Silicon Advances Commercial Fumed Silica Production Through Strategic Joint Venture
MONTREAL, Feb. 12, 2026 – HPQ Silicon Inc., a technology company specializing in advanced materials and critical process development, has taken a significant step toward commercializing its proprietary fumed silica technology. The company announced that its wholly owned subsidiary, HPQ Silica Polvere Inc., has signed a non-binding memorandum of understanding with a strategic industrial partner to advance the construction and operation of a commercial-scale fumed silica production plant.
Project Details and Financial Structure
The proposed project involves the formation of a jointly owned operating company that would build and operate a 1,000-tonne-per-year commercial fumed silica facility. The estimated total project value stands at US$20.0 million, approximately C$27.3 million. The strategic partner, whose identity remains confidential for competitive reasons, has already secured project financing and would fund the construction of the facility.
The plant would be designed and built by PyroGenesis Inc., utilizing HSPI's proprietary plasma-based Fumed Silica Reactor technology. This collaboration represents a significant milestone in bringing innovative materials technology to commercial scale.
Commercial Structure and Strategic Vision
Under the contemplated structure, the joint venture would own and operate the facility, with production sold through an offtake arrangement to the strategic partner. HPQ Silica Polvere Inc. would receive recurring royalties on each kilogram of fumed silica sold, providing the company with long-term exposure to operating revenues while maintaining a capital-efficient profile.
Bernard Tourillon, President and CEO of HPQ Silicon and HPQ Silica Polvere Inc., commented on the development: "The project and joint venture under consideration are supported by secured financing and an industrial partner with defined market requirements. While this remains subject to technical validation and final agreements, it reflects tangible market interest in deploying our technology at scale."
Technical Validation and Next Steps
Progress toward final agreements remains contingent on the completion of ongoing third-party testing and validation of fumed silica produced by HSPI's existing FSR pilot plant. Production samples have already been delivered to both the strategic partner and an independent specialty testing laboratory in the United States.
These tests are focused on confirming chemical and compositional characteristics required for targeted commercial applications. The validation process represents a critical step in moving from pilot-scale production to full commercial deployment.
Scalable Business Model
Management views this approach as a scalable pathway to commercial deployment rather than a single, stand-alone facility. The structure is designed to align HSPI and HPQ's interests with long-term production performance while creating a platform that can be replicated across multiple sites as demand grows.
This strategic move positions HPQ Silicon to capitalize on growing market demand for advanced materials while leveraging its proprietary technology through a partnership model that minimizes capital requirements while maximizing long-term revenue potential.
